Diadema-Partners-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "ASND",
  "EWTX",
  "TRVI",
  "CNTA",
  "NKTR",
  "ARGX",
  "JAZZ",
  "TGTX",
  "PCRX",
  "ALNY",
  "FOLD",
  "MREO",
  "RXRX",
  "SWTX",
  "ANAB",
  "ALT",
  "OLMA",
  "RLAY",
  "TERN",
  "SMMT",
  "REPL",
  "KROS",
  "SAGE",
  "ALEC",
  "SRRK",
  "APGE",
  "NBIX",
  "KALV",
  "MNKD",
  "PRQR",
  "SGMT",
  "UBX",
  "ATYR",
  "ZYME",
  "PFE",
  "AMGN",
  "REGN",
  "AGIO",
  "MRNA",
  "RYTM",
  "SLNO",
  "QURE",
  "COGT",
  "ETNB",
  "RVPH",
  "GOSS",
  null,
  "ELDN",
  "EOLS",
  "IMCR",
  "IMUX",
  "NVO",
  "URGN",
  "VERV",
  "VTGN",
  "VKTX",
  "VRDN",
  "RARE",
  "PCVX",
  "BMEA",
  "BMRN",
  "BBIO",
  "CADL",
  "CRDF",
  "CAPR",
  "SAVA",
  "CMPX",
  "CORT",
  "CRSP",
  "CYTK",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 72
Total Value: 201693517
Accession Number: 0001892688-25-000116
Form Type: 13F-HR
CIK: diadema-partners-lp
Manager Name: Diadema-Partners-Lp

Data Enrichment

99% identified

71 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

72 positions • $201.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 4

Sort by:

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:60.0K

Value:$2.6M

% of Portfolio:1.3% ($2.6M/$201.7M)

MANNKIND CORP

MNKD|56400P706

Shares:519.9K

Value:$2.6M

% of Portfolio:1.3% ($2.6M/$201.7M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:164.0K

Value:$2.4M

% of Portfolio:1.2% ($2.4M/$201.7M)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:162.1K

Value:$2.2M

% of Portfolio:1.1% ($2.2M/$201.7M)

ANAPTYSBIO, INC

ANAB|032724106

Shares:117.3K

Value:$2.2M

% of Portfolio:1.1% ($2.2M/$201.7M)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:98.2K

Value:$2.2M

% of Portfolio:1.1% ($2.2M/$201.7M)

Zymeworks Inc.

ZYME|98985Y108

Shares:179.3K

Value:$2.1M

% of Portfolio:1.1% ($2.1M/$201.7M)

Altimmune, Inc.

ALT|02155H200

Shares:418.8K

Value:$2.1M

% of Portfolio:1.0% ($2.1M/$201.7M)

Vaxcyte, Inc.

PCVX|92243G108

Shares:51.6K

Value:$1.9M

% of Portfolio:1.0% ($1.9M/$201.7M)

Scholar Rock Holding Corp

SRRK|80706P103

Shares:57.9K

Value:$1.9M

% of Portfolio:0.9% ($1.9M/$201.7M)

89bio, Inc.

ETNB|282559103

Shares:231.4K

Value:$1.7M

% of Portfolio:0.8% ($1.7M/$201.7M)

uniQure N.V.

QURE|N90064101

Shares:154.1K

Value:$1.6M

% of Portfolio:0.8% ($1.6M/$201.7M)

Moderna, Inc.

MRNA|60770K107

Shares:52.1K

Value:$1.5M

% of Portfolio:0.7% ($1.5M/$201.7M)

Sage Therapeutics, Inc.

SAGE|78667J108

Shares:183.5K

Value:$1.5M

% of Portfolio:0.7% ($1.5M/$201.7M)

Ascendis Pharma A/S

ASND|04351P101

Shares:8.3K

Value:$1.3M

% of Portfolio:0.6% ($1.3M/$201.7M)

Viking Therapeutics, Inc.

VKTX|92686J106

Shares:50.0K

Value:$1.2M

% of Portfolio:0.6% ($1.2M/$201.7M)

Cogent Biosciences, Inc.

COGT|19240Q201

Shares:201.4K

Value:$1.2M

% of Portfolio:0.6% ($1.2M/$201.7M)

KalVista Pharmaceuticals, Inc.

KALV|483497103

Shares:103.3K

Value:$1.2M

% of Portfolio:0.6% ($1.2M/$201.7M)

Mereo BioPharma Group plc

MREO|589492107

Shares:515.2K

Value:$1.2M

% of Portfolio:0.6% ($1.2M/$201.7M)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:180.0K

Value:$1.1M

% of Portfolio:0.6% ($1.1M/$201.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	60.0K	QoQ NEW(+60.0K) YoY-	All Managers (Combined)	$2.6M	1.3% ($2.6M/$201.7M)	QoQ NEW(+$2.6M) YoY-
MANNKIND CORP(MNKDcusip56400P706)	519.9K	QoQ NEW(+519.9K) YoY-	All Managers (Combined)	$2.6M	1.3% ($2.6M/$201.7M)	QoQ NEW(+$2.6M) YoY-
Centessa Pharmaceuticals plc(CNTAcusip152309100)	164.0K	QoQ +24.40% (+32.2K) YoY-	All Managers (Combined)	$2.4M	1.2% ($2.4M/$201.7M)	QoQ +6.80% (+$150.3K) YoY-
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	162.1K	QoQ +227.54% (+112.6K) YoY-	All Managers (Combined)	$2.2M	1.1% ($2.2M/$201.7M)	QoQ +130.32% (+$1.2M) YoY-
ANAPTYSBIO, INC(ANABcusip032724106)	117.3K	QoQ -45.44% (-97.7K) YoY-	All Managers (Combined)	$2.2M	1.1% ($2.2M/$201.7M)	QoQ -23.39% (-$666.0K) YoY-
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	98.2K	QoQ +7125.90% (+96.8K) YoY-	All Managers (Combined)	$2.2M	1.1% ($2.2M/$201.7M)	QoQ +5853.97% (+$2.1M) YoY-
Zymeworks Inc.(ZYMEcusip98985Y108)	179.3K	QoQ NEW(+179.3K) YoY-	All Managers (Combined)	$2.1M	1.1% ($2.1M/$201.7M)	QoQ NEW(+$2.1M) YoY-
Altimmune, Inc.(ALTcusip02155H200)	418.8K	QoQ +109.40% (+218.8K) YoY-	All Managers (Combined)	$2.1M	1.0% ($2.1M/$201.7M)	QoQ +45.21% (+$652.0K) YoY-
Vaxcyte, Inc.(PCVXcusip92243G108)	51.6K	QoQ +416.00% (+41.6K) YoY-	All Managers (Combined)	$1.9M	1.0% ($1.9M/$201.7M)	QoQ +138.01% (+$1.1M) YoY-
Scholar Rock Holding Corp(SRRKcusip80706P103)	57.9K	QoQ +34.70% (+14.9K) YoY-	All Managers (Combined)	$1.9M	0.9% ($1.9M/$201.7M)	QoQ +0.20% (+$3.8K) YoY-
89bio, Inc.(ETNBcusip282559103)	231.4K	QoQ NEW(+231.4K) YoY-	All Managers (Combined)	$1.7M	0.8% ($1.7M/$201.7M)	QoQ NEW(+$1.7M) YoY-
uniQure N.V.(QUREcusipN90064101)	154.1K	QoQ +54.10% (-54.1K) YoY-	All Managers (Combined)	$1.6M	0.8% ($1.6M/$201.7M)	QoQ -7.50% (-$132.5K) YoY-
Moderna, Inc.(MRNAcusip60770K107)	52.1K	QoQ NEW(+52.1K) YoY-	All Managers (Combined)	$1.5M	0.7% ($1.5M/$201.7M)	QoQ NEW(+$1.5M) YoY-
Sage Therapeutics, Inc.(SAGEcusip78667J108)	183.5K	QoQ NEW(+183.5K) YoY-	All Managers (Combined)	$1.5M	0.7% ($1.5M/$201.7M)	QoQ NEW(+$1.5M) YoY-
Ascendis Pharma A/S(ASNDcusip04351P101)	8.3K	QoQ -67.07% (-17.0K) YoY-	All Managers (Combined)	$1.3M	0.6% ($1.3M/$201.7M)	QoQ -62.72% (-$2.2M) YoY-
Viking Therapeutics, Inc.(VKTXcusip92686J106)	50.0K	QoQ NEW(+50.0K) YoY-	All Managers (Combined)	$1.2M	0.6% ($1.2M/$201.7M)	QoQ NEW(+$1.2M) YoY-
Cogent Biosciences, Inc.(COGTcusip19240Q201)	201.4K	QoQ +123.77% (+111.4K) YoY-	All Managers (Combined)	$1.2M	0.6% ($1.2M/$201.7M)	QoQ +71.84% (+$504.4K) YoY-
KalVista Pharmaceuticals, Inc.(KALVcusip483497103)	103.3K	QoQ NEW(+103.3K) YoY-	All Managers (Combined)	$1.2M	0.6% ($1.2M/$201.7M)	QoQ NEW(+$1.2M) YoY-
Mereo BioPharma Group plc(MREOcusip589492107)	515.2K	QoQ NEW(+515.2K) YoY-	All Managers (Combined)	$1.2M	0.6% ($1.2M/$201.7M)	QoQ NEW(+$1.2M) YoY-
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	180.0K	QoQ NEW(+180.0K) YoY-	All Managers (Combined)	$1.1M	0.6% ($1.1M/$201.7M)	QoQ NEW(+$1.1M) YoY-